marijuana stock news

SOL Global Investments Announces Date Change For Their Conference Call To Discuss Fiscal 2019 Results And Corporate Updates to August 8th, 2019 at 4:00PM ET

Brady Cobb , Chief Executive Officer, will host the call starting at 4:00 p.m. Eastern Time . A question and answer session will immediately follow an initial presentation on SOL Global’s fiscal 2019 financial results and a corporate update. Additional participants from SOL Global will include Andy DeFrancesco , Chief Investment Officer and Chairman, Peter Liabotis , Chief Financial Officer and Paul Norman , Chief Executive Officer of SOL Global portfolio company HeavenlyRx.

Dial-in Information:

U.S. Dial-in Number: (646) 982-0366
U.S. Toll-Free Number: (866) 793-5054
International Access: uberconference.com/amwpr

About SOL Global Investments Corp.

SOL Global is an international investment company with a focus on, but not limited to, cannabis and cannabis related companies in legal U.S. states, the hemp and CBD marketplaces and the emerging European cannabis and hemp marketplaces. Its strategic investments and partnerships across cultivation, distribution and retail complement the company’s R&D program with the University of Miami . It is this comprehensive approach that is positioning SOL Global as a future frontrunner in the United States’ medical cannabis industry.

SOURCE SOL Global Investments Corp.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$MJNA Company KannaLife Sciences Featured in CNN’s Documentary: Weed 3

Medical Marijuana, Inc.’s Portfolio Company KannaLife Sciences Featured in CNN’s Documentary: Weed…

3 Marijuana Stocks To Buy Now And Sell When The Sectors Up

These Top Marijuana Stocks Are Keeping Hopes Alive

 Village Farms International, Inc. (VFF) Investee DutchCanGrow Provides Update on Production Licensing Lottery for Netherlands

Village Farms International’s Investee DutchCanGrow Provides Update on Production Licensing Lottery for…

AbbVie Inc. (ABBV) Submits Application for Risankizumab (SKYRIZI®) in Moderate to Severe Crohn’s Disease

AbbVie Submits Application for Risankizumab (SKYRIZI®) in Moderate to Severe Crohn’s Disease…